Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy.
Gallagher
Martin J
MJ
Eisenman
Lawrence N
LN
Brown
Kelly M
KM
Erbayat-Altay
Ebru
E
Hecimovic
Hrvoje
H
Fessler
A James
AJ
Attarian
Hrayr P
HP
Gilliam
Frank G
FG
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D004569:Electroencephalography / Q000187:drug effects* / Q000706:statistics & numerical data; D004829:Epilepsy, Generalized / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000077287:Levetiracetam; D008991:Monitoring, Physiologic / Q000379:methods / Q000706:statistics & numerical data; D010889:Piracetam / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D018709:Statistics, Nonparametric
D000077287:Levetiracetam; D010889:Piracetam